Skip to main content
. 2022 Nov 23;9:973688. doi: 10.3389/fmed.2022.973688

FIGURE 6.

FIGURE 6

(A) Network estimates mortality among JAK inhibitors. (B) Rank probabilities among JAK inhibitors for mortality based on the network meta-analysis. (C) Network estimates adverse events among JAK inhibitors. (D) Rank probabilities among JAK inhibitors for adverse events based on the network meta-analysis. CI, confidence interval.